Skip to main content
Equibles
MRLN logo

MRLN · Merlin, Inc. · Metrics

Track MRLN — free

Use MRLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.87 +0.09 (+12.22%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Customer concentration — key customers 90% of revenue

Key customers — 90% of revenue (the three months ended March 31, 2026)

“During the three months ended March 31, 2026 and 2025, the Company generated $1,002 and $868 in revenue, with a significant amount (> 90%) of this revenue coming from the U.S. government (refer to Note 4. Revenue Recognition from Contracts with Customers for further information).”
View the 10-Q filed May 15, 2026
Market Cap
$78.34M
Shares
101.07M
Volume · Nov 6 864.6K Avg daily vol (3M) 2.48M

MRLN metrics

55 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.87
Market cap
$78.34M

Price action

23 metrics
Price change (1W)
-26.2%
Price change (30D)
-45.0%
Price change (3M)
-81.8%
Price change (6M)
-90.7%
Price change (YTD)
-92.8%
Price change (1Y)
-92.8%
Trailing year
Price change (5Y)
—
52-week high
$16.09
52-week low
$0.78
Change from 52-week high
-95.2%
Change from 52-week low
+0.0%
Annualized volatility
123.0%
Annualized volatility (3M)
124.0%
Implied volatility (30D)
227.6%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.2
RSI (14D)
28.4
Price vs SMA 50
-57.7%
Price vs SMA 200
-87.7%
Avg volume (3M)
2.49M
Relative volume
0.9
Average dollar volume
$4.94M

Company

3 metrics
Sector
Industrials
Industry
Aerospace & Defense
Shares outstanding
101.07M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-145.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-12
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$41.99M
Net income (TTM)
−$113.81M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.06

Growth

11 metrics
Revenue growth YoY
-29.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+28.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-55.0%
Debt / equity
—
Current ratio
14.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
14.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$183.87M
Latest balance sheet
Cash & equivalents
$183.55M
Total assets
$206.98M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$27.00M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.63M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
63
13F filer change QoQ
+34
Institutional ownership
19.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
9.8%
Private-fund adviser ownership
8.4%
Active holders' share change QoQ
+280.1%
Holder tenure
1.3
Price vs estimated holder cost
-35.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.4%

Short interest

3 metrics
Short interest
11.6%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2028707 CUSIP 590106100 13F (30d) 21 filings 21 filers Visit website Investor relations